Symbol: |
LINC00466
|
Description: |
null
|
Location: |
null
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:122
Gene |
Compound |
Gen_sig |
Exp_pattern |
LINC00466 |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.045 |
Down |
LINC00466 |
NSC 138333 |
0.011 |
Up |
LINC00466 |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.044 |
Up |
LINC00466 |
NSC 148201 |
0.04 |
Down |
LINC00466 |
1-Azabicyclo[2.2.2]octan-3-one, 2-(4-morpholinylmethyl)- |
0.031 |
Up |
LINC00466 |
NSC 168197 |
0.011 |
Up |
LINC00466 |
Bromocriptine methanesulfonate |
0.022 |
Up |
LINC00466 |
Hydrazinecarbothioamide, 2,2'-(1,5-dimethyl-1,5-pentanediylidene)bis[N-methyl- |
0.045 |
Up |
LINC00466 |
Chrysanthin |
0.028 |
Up |
LINC00466 |
1H-Pyrazole-5-carboxylic acid, 4,5-dihydro-1,3-diphenyl-, potassium salt |
0.023 |
Up |
LINC00466 |
Buclizine Hydrochloride |
0.011 |
Up |
LINC00466 |
Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester |
0.028 |
Up |
LINC00466 |
Methanaminium, N-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) |
0.014 |
Down |
LINC00466 |
Cycloalkannin |
0.014 |
Up |
LINC00466 |
Propanedinitrile, 1H-indazol-6-ylhydrazono- |
0.013 |
Up |
Expression pattern: Sensitivity / Resistance
Total:9 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:null
SNP |
Gene |
SNP_location |
SNP_allele |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|